A team of researchers from the University of Michigan and the University of Emory reported positive results from a phase 1 clinical study utilizing stem cells to treat amyotrophic lateral sclerosis [ALS], Lou Gehrig’s disease. In addition to verifying the safety of the new procedure, the trial revealed some progress in preventing further disease damage to the motor nerves by improving their cellular environment.
The initial success of the phase 1 trial has inspired a research team from Cedars-Sinai Medical Center to conduct the procedure using stem cells genetically modified to secrete protective hormones into patients. This would be an example of translational genomics, in which the researchers can extract autologous (the patient’s own) stem cells, correct the defective gene causing the disease, and then transplant the cells back into the patient to regenerate healthy tissue.
The research is an example of how scientists are gaining insights that will facilitate more effective treatments leading to better outcomes. To learn more about the value of preserving your own mesenchymal stem cells for use in future therapies and how to bank your own stem cells through a non-evasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.